AI Assisted Detection of Fractures on X-Rays (FRACT-AI) (FRACT-AI)

April 8, 2024 updated by: Alex Novak, Oxford University Hospitals NHS Trust

FRACT-AI: Evaluating the Impact of Artificial Intelligence-Enhanced Image Analysis on the Diagnostic Accuracy of Frontline Clinicians in the Detection of Fractures on Plain X-Ray

This study has been added as a sub study to the Simulation Training for Emergency Department Imaging 2 study (ClinicalTrials.gov ID NCT05427838). This work aims to evaluate the impact of an Artificial Intelligence (AI)-enhanced algorithm called Boneview on the diagnostic accuracy of clinicians in the detection of fractures on plain XR (X-Ray). The study will create a dataset of 500 plain X-Rays involving standard images of all bones other than the skull and cervical spine, with 50% normal cases and 50% containing fractures. A reference 'ground truth' for each image to confirm the presence or absence of a fracture will be established by a senior radiologist panel. This dataset will then be inferenced by the Gleamer Boneview algorithm to identify fractures. Performance of the algorithm will be compared against the reference standard. The study will then undertake a Multiple-Reader Multiple-Case study in which clinicians interpret all images without AI and then subsequently with access to the output of the AI algorithm. 18 clinicians will be recruited as readers with 3 from each of six distinct clinical groups: Emergency Medicine, Trauma and Orthopedic Surgery, Emergency Nurse Practitioners, Physiotherapy, Radiology and Radiographers, with three levels of seniority in each group. Changes in reporting accuracy (sensitivity, specificity), confidence, and speed of readers in two sessions will be compared. The results will be analyzed in a pooled analysis for all readers as well as for the following subgroups: Clinical role, Level of seniority, Pathological finding, Difficulty of image. The study will demonstrate the impact of an AI interpretation as compared with interpretation by clinicians, and as compared with clinicians using the AI as an adjunct to their interpretation. The study will represent a range of professional backgrounds and levels of experience among the clinical element. The study will use plain film x-rays that will represent a range of anatomical views and pathological presentations, however x-rays will present equal numbers of pathological and non-pathological x-rays, giving equal weight to assessment of specificity and sensitivity. Ethics approval has already been granted, and the study will be disseminated through publication in peer-reviewed journals and presentation at relevant conferences.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

21

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • United Kingdom
    • Oxfordshire
      • Oxford, Oxfordshire, United Kingdom, OX3 9DU
        • Recruiting
        • Oxford University Hospitals NHS Foundation Trust
        • Contact:
        • Sub-Investigator:
          • Abdalá T Espinosa Morgado, MSc

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Emergency medicine doctors, trauma and orthopaedic surgeons, emergency nurse practitioners, physiotherapists, general radiologists and radiographers reviewing X-rays as part of their routine clinical practice, currently working in the National Health Service (NHS).

Readers will be recruited from across 5 NHS organisations which comprise the Thames Valley Emergency Medicine Research Network (www.TaVERNresearch.org):

  • Oxford University Hospitals NHS Foundation Trust
  • Royal Berkshire NHS Foundation Trust
  • Buckinghamshire Healthcare NHS Trust
  • Frimley Health NHS Foundation Trust
  • Milton Keynes University Hospital NHS Foundation Trust

Description

Inclusion Criteria:

  • Emergency medicine doctors, trauma and orthopaedic surgeons, emergency nurse practitioners, physiotherapists, general radiologists and radiographers reviewing X-rays as part of their routine clinical practice.
  • Currently working in the National Health Service (NHS).

Exclusion Criteria:

  • Non-radiology physicians with previous formal postgraduate XR reporting training.
  • Non-radiology physicians with previous career in radiology

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Readers/participants

Reader Selection: 18 readers will be selected from the following five clinical specialty groups (3 readers each):

  • Emergency Medicine
  • Trauma and Orthopaedic Surgery
  • Emergency Nurse Practitioners
  • Physiotherapy
  • General Radiology
  • Radiographers

And from the following level of seniority/experience:

  • Consultant/Senior/Equivalent - >10yrs experience
  • Middle Grade/Registrar/Equivalent - 5-10yrs experience
  • Junior Grade/Senior House Officer/Equivalent - <5yrs experience

Each specialty reader group will include 1 reader at each level of experience.

Readers will be recruited from across 5 NHS organisations which comprise the Thames Valley Emergency Medicine Research Network (www.TaVERNresearch.org):

  • Oxford University Hospitals NHS Foundation Trust
  • Royal Berkshire NHS Foundation Trust
  • Buckinghamshire Healthcare NHS Trust
  • Frimley Health NHS Foundation Trust
  • Milton Keynes University Hospital NHS Foundation Trust
Other: Cases reading

The reading will be done remotely via the Report and Image Quality Control site (www.RAIQC.com), an online platform allowing medical imaging viewing and reporting. Participants can work from any location, but the work must be done from a computer with internet access. For avoidance of doubt, the work cannot be performed from a phone or tablet.

The project is divided into two phases and participants are required to complete both phases. The estimated total involvement in the project is up to 20-24 hours.

Phase 1: Time allowed: 2 weeks

- Participants must review 500 X-rays and express a clinical opinion through a structured reporting template (multiple choice, no open text required).

Rest/washout period - Time allowed: 4 weeks, to mitigate the effects of recall bias.

Phase 2 - Time allowed: 2 weeks

- Review 500 X-rays together with an AI report for each case and express their clinical opinion through the same structured reporting template used in Phase 1.
Ground truthers
Two consultant musculoskeletal radiologists. A third senior musculoskeletal radiologist's opinion (>20 years experience) will undertake arbitration.
Other: Ground truthing
Two consultant musculoskeletal radiologists will independently review the images to establish the 'ground truth' findings on the XRs, where a consensus is reached this will then be used as the reference standard. In the case of disagreement, a third senior musculoskeletal radiologist's opinion (>20 years experience) will undertake arbitration. A difficulty score will be assigned to each abnormality by the ground truthers using a 4-point Likert scale (1 being easy/obvious to 4 being hard/poorly visualised).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Performance of AI algorithm: sensitivity
Time Frame: During 4 weeks of reading time
Evaluation of the Gleamer Boneview algorithm will be performed comparing it to the reference standard in order to determine sensitivity.
During 4 weeks of reading time
Performance of AI algorithm: specificity
Time Frame: During 4 weeks of reading time
Evaluation of the Gleamer Boneview will be performed comparing it to the reference standard in order to determine specificity.
During 4 weeks of reading time
Performance of AI algorithm: Area under the ROC Curve (AU ROC)
Time Frame: During 4 weeks of reading time
Evaluation of the Gleamer Boneview algorithm will be performed comparing it to the reference standard. Continuous probability score from the algorithm will be utilised for the ROC analyses, while binary classification results with a predefined operating cut-off will be used for evaluation of sensitivity, specificity, positive predictive value, and negative predictive value.
During 4 weeks of reading time
Performance of readers with and without AI assistance: Sensitivity
Time Frame: During 4 weeks of reading time
The study will include two sessions (with and without AI overlay), with all 18 readers reviewing all 500 XR cases each time separated by a washout period to mitigate recall bias. The cases will be randomised between the two reads and for every reader.
During 4 weeks of reading time
Performance of readers with and without AI assistance: Specificity
Time Frame: During 4 weeks of reading time
The study will include two sessions (with and without AI overlay), with all 18 readers reviewing all 500 XR cases each time separated by a washout period to mitigate recall bias. The cases will be randomised between the two reads and for every reader.
During 4 weeks of reading time
Performance of readers with and without AI assistance: Area under the ROC Curve (AU ROC)
Time Frame: During 4 weeks of reading time
The study will include two sessions (with and without AI overlay), with all 18 readers reviewing all 500 XR cases each time separated by a washout period to mitigate recall bias. The cases will be randomised between the two reads and for every reader.
During 4 weeks of reading time
Reader speed with vs without AI assistance.
Time Frame: During 4 weeks of reading time
Mean time taken to review a XR, with vs without AI assistance.
During 4 weeks of reading time

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Oxford University Hospitals NHS Trust

Collaborators

Gleamer

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 8, 2024

Primary Completion (Estimated)

October 1, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

November 8, 2023

First Submitted That Met QC Criteria

November 8, 2023

First Posted (Actual)

November 14, 2023

Study Record Updates

Last Update Posted (Actual)

April 10, 2024

Last Update Submitted That Met QC Criteria

April 8, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 310995-C

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fractures, Closed

Clinical Trials on Cases reading

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe